Home › NDC Lookup › RxCUI directory › RxCUI 207014

10 ML methocarbamol 100 MG/ML Injection [Robaxin] — RxCUI 207014

RxNorm drug concept · Semantic branded drug
RxCUI 207014 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI207014
Official name10 ML methocarbamol 100 MG/ML Injection [Robaxin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asRobaxin 1000 MG per 10 ML Injection; ROBAXIN 1000 MG in 10 ML Injection
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)430 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methocarbamol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Methocarbamol is a muscle relaxant that works through your central nervous system — your brain and spinal cord — rather than directly on the muscles themselves. It's thought to red...
  • What exactly does methocarbamol do? Will it make my muscles stop hurting?
  • You really should not. Methocarbamol already causes drowsiness and slows your central nervous system down. Adding alcohol on top of that significantly increases those effects — we'...
  • Be careful, especially when you first start taking it. Methocarbamol can impair your alertness, coordination, and reaction time. Don't drive or operate heavy machinery until you kn...
📖 Read our full Methocarbamol guide →

🕸️ Concept Web — How 10 ML methocarbamol 100 MG/ML Injection [Robaxin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 10 ML methocarbamol 100 MG/ML Injection [Robaxin] RxCUI 207014

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Methocarbamol 6845
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Robaxin 202955
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methocarbamol Injection 1740942
    • Methocarbamol Injectable Product 1162230
    • Methocarbamol Injection [Robaxin] 1740944
    • Robaxin Injectable Product 1185925
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Methocarbamol 100 MG/ML [Robaxin] SBDC · 567810
  • Methocarbamol Injection [Robaxin] SBDF · 1740944
  • Robaxin Injectable Product SBDG · 1185925
  • Robaxin BN · 202955

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 207014 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00641-6103-10 10 VIAL in 1 CARTON (0641-6103-10) / 10 mL in 1 VIAL (0641-... ROBAXIN Hikma Pharmaceuticals USA Inc. 2023-10-04
00641-6103-25 25 VIAL in 1 CARTON (0641-6103-25) / 10 mL in 1 VIAL (0641-... ROBAXIN Hikma Pharmaceuticals USA Inc. 1959-06-16
00641-6217-10 10 VIAL in 1 CARTON (0641-6217-10) / 10 mL in 1 VIAL (0641-... ROBAXIN Hikma Pharmaceuticals USA Inc. 2023-10-04
00641-6217-25 25 VIAL in 1 CARTON (0641-6217-25) / 10 mL in 1 VIAL (0641-... ROBAXIN Hikma Pharmaceuticals USA Inc. 2017-10-17
Observed labelers: Hikma Pharmaceuticals USA Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2800 Methocarbamol injection 4 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.